Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Allogeneic Transplant and Gene Therapy

Hematology/Oncology Clinics of North America(2022)10.1016/j.hoc.2022.06.007Source: DataRank Database

Allogeneic Transplant and Gene Therapy is a research paper published in Hematology/Oncology Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.55)OA: greenTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Mark C. Walters ORCID,Courtney D. Fitzhugh ORCID,Rialnat AdeBisi Lawal

Live enrichment

PubMed:36400545 PMC:PMC9681017 OpenAlex:https://openalex.org/W4309112014

National Heart, Lung, and Blood Institute

Grant: 1U01HL156620-01

Intramural NIH HHS

Grant: ZIA HL006211

NHLBI NIH HHS

Grant: U01 HL156620

Intramural NIH HHS

Grant: Z99 HL999999

National Institutes of Health

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2023

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9681017

publisherhttps://api.elsevier.com/content/article/PII:S088985882200065X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S088985882200065X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.hoc.2022.06.007

Fields of Study

Hemoglobinopathies and Related DisordersCRISPR and Genetic EngineeringPrenatal Screening and DiagnosticsHumansHematopoietic Stem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseAnemia, Sickle CellGenetic TherapyAllografts

MeSH Terms

Anemia, Sickle CellGraft vs Host DiseaseHumansGenetic TherapyHematopoietic Stem Cell TransplantationTransplantation ConditioningAllografts

Keywords

Genetic enhancementHuman leukocyte antigenMedicineDiseaseHematopoietic cellImmunologyGraft-versus-host diseaseTransplantationSiblingHematopoietic stem cell transplantationCell therapyGenome editingOncologyGeneHaematopoiesisStem cellInternal medicineAntigenBiologyCRISPRGeneticsPsychologyGene therapyGraft versus host diseaseSickle Cell DiseaseAllogeneic TransplantGene EditingHaploidenticalHematopoietic Cell TransplantMatched Sibling Donor

Sustainable Development Goals

SDG 0: Good health and well-being

Allogeneic Transplant and Gene Therapy

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)